查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1521201

2024-2032 年自動注射器市場報告（按類型（一次性自動注射器、可重複使用自動注射器）、應用（類風濕關節炎、過敏反應、多發性硬化症等）、最終用戶（家庭護理機構、醫院和診所）和地區

Autoinjector Market Report by Type (Disposable Autoinjectors, Reusable Autoinjectors), Application (Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, and Others), End User (Home Care Settings, Hospitals and Clinics), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年全球自動注射器市場規模達22億美元。

自動注射器是自我注射裝置，有助於透過皮下或肌肉內途徑輸送藥物。它們具有多種優勢，例如劑量準確性和提高患者依從性，有助於減少患者的針頭恐懼症，減少隱藏針頭造成的針刺傷害，並提高醫療保健專業人員的便利性和效率。它們廣泛用於緊急情況，例如過敏反應、偏頭痛、癲癇持續狀態、牛皮癬、糖尿病、多發性硬化症和類風濕性關節炎。因此，自動注射器在全球的醫院、診所和家庭護理中心中得到了廣泛的應用。

自動注射器市場趨勢：

目前，關節炎、氣喘、癌症、慢性阻塞性肺病（COPD）和阿茲海默症的盛行率有所上升。這加上對自行給藥藥物的需求不斷成長，是推動市場的關鍵因素之一。此外，一些國家的政府正在採取舉措，促進在學校使用自動注射器。再加上個人對自動注射器好處的認知不斷提高，正在推動市場的成長。此外，主要市場參與者正在廣泛投資於研發（R＆D）活動，以開發簡單、經濟高效且基於新技術的自動注射器，用於治療類風濕性關節炎和多發性硬化症。除此之外，擴大採用標靶療法來改變癌細胞內的蛋白質並防止腫瘤中新血管的形成，這為行業投資者提供了利潤豐厚的成長機會。此外，世界各地蓬勃發展的醫療保健產業正在推動市場的成長。促進成長的其他一些因素包括監管批准數量的增加、技術進步、生物製劑專利到期以及自動注射器通用版本的可用性。

本報告回答的關鍵問題

  • 2023 年全球自動注射器市場規模有多大？ 2024-2032年全球自動注射器市場的預期成長率是多少？
  • 推動全球自動注射器市場的關鍵因素是什麼？
  • COVID-19 對全球自動注射器市場有何影響？
  • 全球自動注射器市場按類型分類是怎樣的？
  • 根據應用，全球自動注射器市場的細分如何？
  • 基於最終用戶的全球自動注射器市場的詳細情形如何？
  • 全球自動注射器市場的主要區域有哪些？
  • 全球自動注射器市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球自動注射器市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：按類型

  • 一次性自動注射器
    • 市場走向
    • 市場預測
  • 可重複使用的自動注射器
    • 市場走向
    • 市場預測

第 7 章：市場區隔：按應用

  • 類風濕關節炎
    • 市場走向
    • 市場預測
  • 過敏反應
    • 市場走向
    • 市場預測
  • 多發性硬化症
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：市場區隔：依最終用戶

  • 家庭護理設置
    • 市場走向
    • 市場預測
  • 醫院和診所
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Amgen Inc.
    • Antares Pharma Inc.
    • Becton Dickinson and Company
    • Bristol-Myers Squibb Company
    • Eisai Co. Ltd.
    • Eli Lilly and Company
    • Haselmeier GmbH (Sulzer Ltd.)
    • Johnson & Johnson
    • Mylan NV (Viatris Inc.)
    • Novartis AG
    • SHL Medical AG
    • Teva Pharmaceutical Industries Ltd.
    • Ypsomed Holding AG
Product Code: SR112024A5436

The global autoinjector market market size reached US$ 2.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.4 Billion by 2032, exhibiting a growth rate (CAGR) of 13.9% during 2024-2032.

Autoinjectors are self-injectable devices that help deliver drugs via the subcutaneous or intramuscular route. They offer several advantages, such as dosage accuracy and improved patient compliance, and help reduce needle phobia of patients, lower needlestick injuries resulting from a hidden needle, and increase the convenience and efficiency of healthcare professionals. They are widely used during emergency conditions, such as anaphylaxis, migraine, status epilepticus, psoriasis, diabetes, multiple sclerosis, and rheumatoid arthritis. As a result, autoinjectors find extensive applications in hospitals, clinics, and home care centers across the globe.

Autoinjector Market Trends:

At present, there is a rise in the prevalence of arthritis, asthma, cancer, chronic obstructive pulmonary disease (COPD) and Alzheimer's disease. This, along with the growing need for self-administrating medicines, represents one of the key factors driving the market. Moreover, governments of several countries are undertaking initiatives to promote the use of autoinjectors in schools. This, coupled with the increasing awareness among individuals about the benefits of autoinjectors, is propelling the growth of the market. In addition, key market players are extensively investing in research and development (R&D) activities to develop simple, cost-effective, and new technology-based autoinjectors for treating rheumatoid arthritis and multiple sclerosis. Besides this, the rising adoption of targeted therapies to alter proteins within cancer cells and prevent the formation of new blood vessels in the tumor is offering lucrative growth opportunities to industry investors. Additionally, the burgeoning healthcare industry around the world is bolstering the growth of the market. Some of the other factors inducing growth are the increasing number of regulatory approvals, technological advancements, patent expiry of biologics and the availability of generic versions of autoinjectors.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global autoinjector market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, application and end user.

Breakup by Type:

Disposable Autoinjectors

Reusable Autoinjectors

Breakup by Application:

Rheumatoid Arthritis

Anaphylaxis

Multiple Sclerosis

Others

Breakup by End User:

Home Care Settings

Hospitals and Clinics

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Amgen Inc., Antares Pharma Inc., Becton Dickinson and Company, Bristol-Myers Squibb Company, Eisai Co. Ltd., Eli Lilly and Company, Haselmeier GmbH (Sulzer Ltd.), Johnson & Johnson, Mylan N.V. (Viatris Inc.), Novartis AG, SHL Medical AG, Teva Pharmaceutical Industries Ltd. and Ypsomed Holding AG.

Key Questions Answered in This Report

  • 1. What was the size of the global autoinjector market in 2023?
  • 2. What is the expected growth rate of the global autoinjector market during 2024-2032?
  • 3. What are the key factors driving the global autoinjector market?
  • 4. What has been the impact of COVID-19 on the global autoinjector market?
  • 5. What is the breakup of the global autoinjector market based on the type?
  • 6. What is the breakup of the global autoinjector market based on the application?
  • 7. What is the breakup of the global autoinjector market based on the end user?
  • 8. What are the key regions in the global autoinjector market?
  • 9. Who are the key players/companies in the global autoinjector market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Autoinjector Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Disposable Autoinjectors
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Reusable Autoinjectors
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Rheumatoid Arthritis
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Anaphylaxis
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Multiple Sclerosis
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Home Care Settings
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Hospitals and Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Amgen Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Antares Pharma Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Becton Dickinson and Company
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Bristol-Myers Squibb Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Eisai Co. Ltd.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Eli Lilly and Company
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Haselmeier GmbH (Sulzer Ltd.)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Johnson & Johnson
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Mylan N.V. (Viatris Inc.)
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Novartis AG
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 SHL Medical AG
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Teva Pharmaceutical Industries Ltd.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis
    • 14.3.13 Ypsomed Holding AG
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Autoinjector Market: Major Drivers and Challenges
  • Figure 2: Global: Autoinjector Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Autoinjector Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Autoinjector Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Autoinjector Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Autoinjector Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Autoinjector Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Autoinjector (Disposable Autoinjectors) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Autoinjector (Disposable Autoinjectors) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Autoinjector (Reusable Autoinjectors) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Autoinjector (Reusable Autoinjectors) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Autoinjector (Rheumatoid Arthritis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Autoinjector (Rheumatoid Arthritis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Autoinjector (Anaphylaxis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Autoinjector (Anaphylaxis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Autoinjector (Multiple Sclerosis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Autoinjector (Multiple Sclerosis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Autoinjector (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Autoinjector (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Autoinjector (Home Care Settings) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Autoinjector (Home Care Settings) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Autoinjector (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Autoinjector (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: North America: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: North America: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: United States: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: United States: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Canada: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Canada: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Asia-Pacific: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Asia-Pacific: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: China: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: China: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Japan: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Japan: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: India: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: India: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: South Korea: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: South Korea: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Australia: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Australia: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Indonesia: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Indonesia: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Others: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Others: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Europe: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Europe: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Germany: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Germany: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: France: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: France: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: United Kingdom: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: United Kingdom: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Italy: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Italy: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Spain: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Spain: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Russia: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Russia: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Others: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Others: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Latin America: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Latin America: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Brazil: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Brazil: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Mexico: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Mexico: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Others: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Others: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Middle East and Africa: Autoinjector Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Middle East and Africa: Autoinjector Market: Breakup by Country (in %), 2023
  • Figure 72: Middle East and Africa: Autoinjector Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Global: Autoinjector Industry: SWOT Analysis
  • Figure 74: Global: Autoinjector Industry: Value Chain Analysis
  • Figure 75: Global: Autoinjector Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Autoinjector Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Autoinjector Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Autoinjector Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Autoinjector Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Autoinjector Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Autoinjector Market: Competitive Structure
  • Table 7: Global: Autoinjector Market: Key Players